ELTX
Elicio Therapeutics Inc.
1.80$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | +1.4% | +1.0% | -1.0% | +5.2% | -8.9% | +1.1% | +0.7% | +1.1% | +1.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.2% | +22.8% | +8.2% | -11.9% | +47.4% | -26.8% | -9.9% | -28.1% | +0.8% | +32.1% | +1.5% | – | |
| – | -7.8% | -17.1% | +2.3% | +14.3% | -11.8% | +6.9% | +4.3% | -2.6% | +25.1% | +2.2% | -5.9% | – | |
| – | -15.5% | +9.3% | +6.8% | -5.4% | +31.0% | -20.6% | -3.5% | -20.3% | +9.9% | +16.6% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | +1,700.0% | +36.1% | +179.6% | +70.8% | -24.8% | +10.2% | +119.6% | -20.9% | +20.8% | +0.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,700.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.